CME Stock CME Group (CME, $284.36) was a top quarterly gainer, rising +15.23%

GET DAILY SIGNALS

Get AI intraday signals

CME - CME Group

Loading...

Price: $284.36

Daily change: +$0.29 (+0.1%)

Daily volume: 1.8M

3-month price change: +$37.59 (+15.23%)

Capitalization: $102.5B

Industry: Investment Banks/Brokers

CME in upward trend: price rose above 50-day moving average on September 26, 2025

CME moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend. In of 55 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 23, 2025. You may want to consider a long position or call options on CME as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CME just turned positive on September 18, 2025. Looking at past instances where CME's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for CME crossed bearishly below the 50-day moving average on August 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CME broke above its upper Bollinger Band on September 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CME entered a downward trend on September 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.511) is normal, around the industry mean (5.307). P/E Ratio (26.165) is within average values for comparable stocks, (29.605). Projected Growth (PEG Ratio) (5.691) is also within normal values, averaging (3.443). Dividend Yield (0.035) settles around the average of (0.024) among similar stocks. CME's P/S Ratio (15.106) is slightly higher than the industry average of (8.463).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.